Kolon TissueGene, Inc. (KOSDAQ:950160)

Kolon TissueGene Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 9, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	8,709,095	6,624,413	1,847,594	655,804	612,433	518,608
Market Cap Growth	106.63%	258.54%	181.73%	7.08%	18.09%	5.93%
Enterprise Value	8,706,567	6,582,678	1,835,745	610,221	540,002	508,454
Last Close Price	103500.00	79600.00	23250.00	9020.00	8890.00	8010.00
PS Ratio	1688.23	1284.12	364.17	176.95	64.77	129.55
PB Ratio	135.91	103.38	12.66	5.70	6.69	13.42
P/TBV Ratio	136.29	103.67	12.68	5.71	6.71	13.49
EV/Sales Ratio	-	1276.03	361.84	164.66	57.11	127.01
Debt / Equity Ratio	1.24	1.24	0.12	0.06	0.08	0.19
Net Debt / Equity Ratio	-0.04	-0.04	0.11	-0.18	-0.56	-0.82
Net Debt / EBITDA Ratio	0.12	0.12	-0.78	1.10	3.50	0.70
Net Debt / FCF Ratio	0.10	0.10	-0.80	0.86	1.91	0.78
Asset Turnover	0.02	0.02	0.03	0.03	0.11	0.06
Inventory Turnover	59.04	59.04	57.42	82.64	19.35	14.10
Quick Ratio	0.23	0.23	0.02	2.01	5.08	2.44
Current Ratio	0.24	0.24	0.10	2.24	5.44	2.69
Return on Equity (ROE)	-183.43%	-183.43%	-25.91%	-16.69%	-17.11%	-109.20%
Return on Assets (ROA)	-4.32%	-4.32%	-7.70%	-10.47%	-11.90%	-43.86%
Return on Capital Employed (ROCE)	-32.70%	-32.70%	-14.60%	-17.00%	-16.60%	-104.10%
Earnings Yield	-2.21%	-2.91%	-1.83%	-2.63%	-1.82%	-9.13%
FCF Yield	-0.29%	-0.38%	-1.11%	-3.72%	-4.38%	-7.82%
Buyback Yield / Dilution	-6.78%	-6.78%	-7.32%	-8.18%	-8.25%	-0.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.